Efficacy of Ledipasvir Plus Sofosbuvir for 8 or 12 Weeks in Patients With Hepatitis C Virus Genotype 2 Infection-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Efficacy of Ledipasvir Plus Sofosbuvir for 8 or 12 Weeks in Patients With Hepatitis C Virus Genotype 2 Infection

Published:2017-05 Issue:6 Volume:152 Page:1366-1371
ISSN:0016-5085
Container-title:Gastroenterology
language:en
Short-container-title:Gastroenterology

Author:

Gane Edward J.,Hyland Robert H.,Yang Yin,Svarovskaia Evguenia,Stamm Luisa M.,Brainard Diana M.,McHutchison John G.,Stedman Catherine A.M.

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference13 articles.

1. Global epidemiology and genotype distribution of the hepatitis C virus;Gower;J Hepatol,2014

2. Sofosbuvir for previously untreated chronic hepatitis C infection;Lawitz;N Engl J Med,2013

3. Sofosbuvir for hepatitis C genotype 2 or 3 in patients without treatment options;Jacobson;N Engl J Med,2013

4. Sofosbuvir and ribavirin in HCV genotypes 2 and 3;Zeuzem;N Engl J Med,2014

5. Review article: the efficacy and safety of sofosbuvir, a novel, oral nucleotide NS5B polymerase inhibitor, in the treatment of chronic hepatitis C virus infection;Koff;Aliment Pharmacol Ther,2014

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hepatitis C virus diversity and treatment outcomes in Benin: a prospective cohort study;The Lancet Microbe;2024-07

2. Hepatitis C Elimination in Rwanda: Progress, Feasibility, and Economic Evaluation;Value in Health;2024-07

3. Comparison of Glecaprevir/Pibrentasvir and Sofosbuvir/Ledipasvir in Patients with Hepatitis C Virus Genotype 1 and 2 in South Korea;The Korean Journal of Gastroenterology;2024-03-25

4. Efficacy and safety of direct-acting antiviral regimen for patients with hepatitis C virus genotype 2: A systematic review and meta-analysis;2023-03-31

5. Nanoconstructs for theranostic application in cancer: Challenges and strategies to enhance the delivery;Frontiers in Pharmacology;2023-03-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3